JOHN PHILIP COGHLAN - 03 Nov 2025 Form 4 Insider Report for Life360, Inc. (LIF)

Role
Director
Signature
/s/ Jay Sood, as Attorney-in-Fact
Issuer symbol
LIF
Transactions as of
03 Nov 2025
Transactions value $
-$309,153
Form type
4
Filing time
05 Nov 2025, 17:10:15 UTC
Previous filing
03 Oct 2025
Next filing
09 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
COGHLAN JOHN PHILIP Director C/O LIFE360, INC., 1900 SOUTH NORFOLK STREET, SUITE 310, SAN MATEO /s/ Jay Sood, as Attorney-in-Fact 05 Nov 2025 0001185999

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIF Common stock Sale -$283K -2.87K -15.61% $98.88 15.5K 03 Nov 2025 Held by the John Coghlan Living Trust F1, F2, F3
transaction LIF Common stock Sale -$25.8K -259 -1.67% $99.47 15.2K 03 Nov 2025 Held by the John Coghlan Living Trust F1, F3, F4
holding LIF Common stock 3.34K 03 Nov 2025 Direct F5
holding LIF Common Stock 55.5K 03 Nov 2025 Held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 6, 2024. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of Company stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.
F2 The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $98.33 to $99.31, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
F3 The Reporting Person transferred 12,110 shares indirectly held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust to the John Coghlan Living Trust, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.
F4 The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $99.36 to $99.60, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
F5 Includes 2,508 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.